Data / Drug companies / Dextromethorphan hydrobromide, doxylamine succinate
Dextromethorphan hydrobromide, doxylamine succinate: 9 companies and 11 products in the FDA NDC directory
Dextromethorphan hydrobromide, doxylamine succinate is listed in the FDA National Drug Code Directory by 9 companies, with 11 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are solution; liquid; tablet, chewable, and the newest product started marketing on July 22, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 9
- Products
- 11
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 1
- Routes
- Oral
- Brand names
- Robitussin Maximum Strength Nighttime Cough DM, Nighttime Cough DM, Night-Time Cough Relief, Tussin DM Nighttime Max, Topcare Tussin DM Max, Nighttime Cough DM, Robitussin Nighttime Cough DM Soft Chews, Night Time Cough
- openFDA record search
- api.fda.gov
Companies that list dextromethorphan hydrobromide, doxylamine succinate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| CVS Woonsocket Prescription Center, Incorporated | 2 | solution | Over the counter monograph drugs | June 24, 2026 |
| Haleon US Holdings LLC | 2 | solution; tablet, chewable | Over the counter monograph drugs | June 19, 2024 |
| Chain Drug Marketing Association | 1 | liquid | Over the counter monograph drugs | July 31, 2018 |
| Discount Drug Mart | 1 | liquid | Over the counter monograph drugs | October 27, 2014 |
| HyVee Inc | 1 | solution | Over the counter monograph drugs | January 13, 2026 |
| Meijer Distribution Inc | 1 | solution | Over the counter monograph drugs | March 14, 2017 |
| Meijer, Inc. | 1 | solution | Over the counter monograph drugs | July 22, 2026 |
| Safeway | 1 | liquid | Over the counter monograph drugs | January 31, 2018 |
| Topco Associates LLC | 1 | solution | Over the counter monograph drugs | May 2, 2019 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Solution | 7 | 63.6% |
| Liquid | 3 | 27.3% |
| Tablet, chewable | 1 | 9.1% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 11 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Antihistamine | 11 |
| Sigma-1 Agonist | 11 |
| Uncompetitive N-methyl-D-aspartate Receptor Antagonist | 11 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.